GBT440

· Global Blood Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GBT440, covering 2019-01-02 to 2020-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF [Phase 2]